• 1. An insight into the hybridization mechanism of hairpin DNA physically immobilized on chemically modified graphenes
  Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471
• 2. An atomic scale study of defects in Co2FeAl
  Ravi Kumar Yadav,R. Govindaraj Phys. Chem. Chem. Phys., 2020,22, 26876-26886
• 3. An antioxidative galactomannan extracted from Chinese Sesbania cannabina enhances immune activation of macrophage cells?
  Chongyang Zhu,Xiaojia Bian,Xin Jia,Ning Tang,Yongqiang Cheng Food Funct., 2020,11, 10635-10644
• 4. An arsenic trioxide nanoparticle prodrug (ATONP) potentiates a therapeutic effect on an aggressive hepatocellular carcinoma model via enhancement of intratumoral arsenic accumulation and disturbance of the tumor microenvironment?
  Xin Fu,Qing-rong Liang,Rong-guang Luo,Yan-shu Li,Xiao-ping Xiao,Lu-lu Yu,Wen-zhe Shan,Guang-qin Fan J. Mater. Chem. B, 2019,7, 3088-3099
• 5. An amphipathic trans-acting phosphorothioate RNA element delivers an uncharged phosphorodiamidate morpholino sequence in mdx mouse myotubes?
  H. V. Jain,D. Verthelyi,S. L. Beaucage RSC Adv., 2017,7, 42519-42528

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Indoles and derivatives Indoles

Comprehensive Overview of Ethyl(1H-indol-4-ylmethyl)amine (CAS No. 342412-30-0): Properties, Applications, and Research Insights

Ethyl(1H-indol-4-ylmethyl)amine (CAS No. 342412-30-0) is a specialized organic compound that has garnered significant attention in pharmaceutical and biochemical research. This compound, characterized by its indole core structure, is a derivative of ethylamine, which plays a pivotal role in the synthesis of bioactive molecules. The presence of the indole moiety, a common scaffold in natural products, makes this compound particularly valuable for drug discovery and development. Researchers are increasingly exploring its potential in modulating neurotransmitter pathways, given its structural similarity to endogenous compounds like tryptamine.

In recent years, the demand for indole-based compounds has surged due to their diverse pharmacological properties. Ethyl(1H-indol-4-ylmethyl)amine is no exception, with studies highlighting its relevance in the design of central nervous system (CNS) therapeutics. Its unique structure allows for interactions with serotonin receptors, making it a candidate for investigating mood disorders and cognitive functions. This aligns with the growing public interest in mental health supplements and neuroprotective agents, topics frequently searched in academic and healthcare forums.

The synthesis of Ethyl(1H-indol-4-ylmethyl)amine involves multi-step organic reactions, often starting from 4-methylindole or its derivatives. Advanced techniques such as microwave-assisted synthesis and catalytic hydrogenation have been employed to improve yield and purity. These methodologies are part of the broader trend toward green chemistry, a hot topic in scientific communities aiming to reduce environmental impact. The compound's physicochemical properties, including solubility and stability, are critical for formulation scientists working on drug delivery systems.

Beyond pharmaceuticals, Ethyl(1H-indol-4-ylmethyl)amine has applications in material science. Its aromatic system and amine functionality enable its use as a building block for functional polymers and supramolecular assemblies. This versatility resonates with industries focused on smart materials and nanotechnology, areas that dominate current research funding and patent filings. Additionally, the compound's fluorescence properties have sparked interest in bioimaging and sensor development, addressing the need for non-invasive diagnostic tools.

Quality control and analytical characterization of Ethyl(1H-indol-4-ylmethyl)amine rely on techniques like high-performance liquid chromatography (HPLC) and nuclear magnetic resonance (NMR) spectroscopy. These methods ensure compliance with regulatory standards, a concern for manufacturers navigating the complexities of global chemical compliance. The compound's spectral data and chromatographic profiles are often shared in open-access databases, supporting the open science movement that promotes collaborative innovation.

As the scientific community continues to explore Ethyl(1H-indol-4-ylmethyl)amine, its potential in personalized medicine and bioconjugation is becoming evident. The rise of precision medicine has increased searches for tailored therapeutic agents, positioning this compound as a subject of future clinical investigations. Furthermore, its compatibility with click chemistry protocols enhances its utility in biomarker discovery, a field driving advancements in early disease detection.

In conclusion, Ethyl(1H-indol-4-ylmethyl)amine (CAS No. 342412-30-0) represents a convergence of chemistry, biology, and materials science. Its multifaceted applications—from CNS drug candidates to advanced materials—reflect the interdisciplinary nature of modern research. With ongoing studies addressing synthetic scalability and mechanistic elucidation, this compound is poised to remain at the forefront of scientific inquiry, answering pressing questions in health and technology.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)